Lind Global Fund II LP 13D/13G Filings for Oragenics, Inc. (OGEN)

Lind Global Fund II LP 13D and 13G filings for Oragenics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
7:29 pm
Sale		 2024-09-30 13G Oragenics, Inc.
OGEN		 Lind Global Fund II LP 0
0.000%		 -265,000decrease
(Position Closed)		 Filing
2024-03-06
4:24 pm
Purchase		 2024-03-01 13G Oragenics, Inc.
OGEN		 Lind Global Fund II LP 265,000
5.900%		 265,000increase
(New Position)		 Filing